Status:
COMPLETED
Botswana Vitamin D Supplementation Study in HIV/AIDS
Lead Sponsor:
Children's Hospital of Philadelphia
Conditions:
HIV
Eligibility:
All Genders
5-51 years
Phase:
PHASE3
Brief Summary
The goal is to determine the vit D supplementation dose that safely results in optimal serum vitamin D (25D) concentrations in HIV-infected children and adults living in Botswana. To do this the inves...
Detailed Description
Many people living with HIV/AIDS in African countries are vit D deficient or insufficient. Vit D deficiency in HIV/AIDS may be due to low dietary vit D intake, increased requirements, malabsorption, s...
Eligibility Criteria
Inclusion
- HIV infection
- Ages 5.0 to 50.9 y
- In usual state of good health
- Subject and/or family commitment to the 12-week study
Exclusion
- Other chronic health conditions unrelated to HIV/AIDS that may affect nutritional status
- Use of vit D supplementation above 400 IU/d
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02189902
Start Date
January 1 2012
End Date
July 1 2012
Last Update
July 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Marina Hospital
Gaborone, Botswana, 0000